Benzodiazepine receptor agonists modulate thymocyte apoptosis through reduction of the mitochondrial transmembrane potential

Japanese Journal of Pharmacology

Volumn 79, Issue 2, 1999, Pages 177-183

  Tanimoto, Yutaka ^a   Onishi, Yoshiaki ^a   Sato, Yutaka ^a   Kizaki, Harutoshi ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Apoptosis; Benzodiazepine; Mitochondrial permeability transition; Proteasome; Thymocyte

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 3,3' DIHEXYLOXACARBOCYANINE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CLONAZEPAM; DEXAMETHASONE; ETOPOSIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PROTEINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; MALE; MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; THYMOCYTE;

EID: 0033065614     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.79.177     Document Type: Article

References (29)

1. Costa E and Guidotti A: Molecular mechanisms in the receptor action of benzodiazepines. Annu Rev Pharmacol Toxicol 19, 531-543 (1979)
2. Pawlikowski M: Immunomodulating effects of peripherally acting benzodiazepines. In Peripheral Benzodiazepine Receptors, Edited by Giessen-Crouse E, pp 125-135, Academic Press, New York (1993)
3. Woods MJ and Williams DC: Multiple forms and locations for the peripheral-type benzodiazepine receptor. Biochem Pharmacol 52, 1805-1814 (1996)
4. Le Fur G, Perrier ML, Vaucher N, Imbault F, Flamier J, Benavides J, Uzan A, Renaut C, Dubroeucq MC and Gueremy C: Peripheral benzodiazepine binding sites: Effects of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carboxamide. I. In vivo studies. Life Sci 32, 1839-1847 (1983)
5. Zoratti M and Szabo I: The mitochondrial permeability transition. Biochim Biophys Acta 1241, 139-176 (1995)
6. Zamzami N, Susin SA and Marchetti P: Mitochondrial control of nuclear apoptosis. J Exp Med 183, 1533-1544 (1996)
7. Pastorino JG, Simbula G, Yamamoto K, Glascott PA Jr, Rothman RJ and Farber JL: The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271, 29792-29798 (1996)
8. Marchetti P, Hirsh T, Zamzami N, Castede M, Decaudin D, Susin SA, Benjamin M and Kroemer G: Mitochondrial permeability transition triggers lymphocyte apoptosis. J Immunol 157, 4830-4836 (1996)
9. Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T and Kizaki H: Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim Biophys Acta 1175, 147-154 (1993)
10. Kizaki H and Onishi Y: Topoisomerase inhibitor-induced apoptosis in thymocytes and lymphoma cells. Adv Enzyme Regul 37, 301-328 (1997)
11. Garnier M, Dimchev AB, Boujrad N, Price JM, Matsuo NA and Papadopoulos V: In vivo reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cell. Mol Pharmacol 45, 201-211 (1994)
12. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsh T, Macho A, Haeffner A, Hirsh F, Geuskens M and Kroemer G: Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184, 1155-1160 (1996)
13. Fearnhead HA, Dinsdale D and Cohen GM: An interleukin-1βconverting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett 375, 283-288 (1995)
14. Tanimoto Y, Onishi Y, Tadakuma T and Kizaki H: Apoptosis of thymocytes and T cell hybridomas is inhibited by proteasome inhibitors. Proceedings of 12th Int Symp FAOBMB, Gene Regulation of Biological Function, p 178 (1996)
15. Cui H, Matsui K, Omura S, Schauer SL, Matulka RA, Sonenshein GE and Ju ST: Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci USA 94, 7515-7520 (1997)
16. Kroermer G, Zamzami N and Susin SA: Mitochondrial control of apoptosis. Immunol Today 18, 44-51 (1997)
17. Pastorino JG, Simbula G, Gilfor E, Gilfor E, Hoek JB and Farber JL: Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates reduction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J Biol Chem 269, 31041-31046 (1994)
18. Verma A, Nye JS and Snyder SH: Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci USA 84, 2256-2260 (1987)
19. Rothman RJ and Farber JL: The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271, 29792-29798 (1996)
20. Berkovich A, Ferrarese C, Cavaletti G, Alho H, Mazorati C, Bianchi G, Guidotti A and Costa E: Topology of two DBI receptors in human lymphocytes. Life Sci 52, 1265-1277 (1993)
21. Cahard D, Canat S, Carayon P, Roque C, Casellas P and Le Fur G: Subcellular localization of peripheral benzodiazepine receptors on human leucocytes. Lab Invest 70, 23-28 (1994)
22. Drugan RC: Are the nonmitochondrial peripheral benzodiazepine receptors on leucocytes a novel intermediary of brain, behavior, and immunity? Lab Invest 70, 1-5 (1994)
23. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM and Osborne BA: Proteasomes play essential role in thymocyte apoptosis. EMBO J 15, 3835-3844 (1996)
24. Stefanell C, Bonavita F, Stanic I, Pignatti C, Farruggia G, Masotti L, Guarnieri C and Caldarera CM: Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome. Biochem J 332, 661-665 (1998)
25. Cui H, Matsui K, Omura S, Schauer SL, Matulka RA, Sonenshin GE and Ju S: Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci USA 94, 7515-7520 (1997)
26. Ramseier H, Lichtensteiger W and Schlumpf M: In vitro inhibition of cellular immune responses by benzodiazepines and PK 11195, effect on mitogen- and alloantigen-driven lymphocyte proliferation and on IL-1, IL-2 synthesis and IL-2 receptor expression. Immunopharmacol Immunotoxicol 15, 557-582 (1993)
27. Moynagh PN, O'Neill LA and Williams DC: Interleukin-1 and phorbol myristate acetate modulate the peripheral-type benzodiazepine receptor in lymphocyte and glial cell. Biochem Pharmacol 46, 821-827 (1993)
28. Schlumpf M, Parmer R and Lichtensteiger W: Prenatal benzodiazepine immunosuppression: possible involvement of peripheral benzodiazepine site. Dev Pharmacol Ther 15, 178-185 (1990)
29. Ferrarese C, Marzorati C, Perego M, Bianchi G, Cavarretta R, Pierpaoli C, Maretti G and Frattola L: Effects of anticonvulsant drugs on peripheral benzodiazepine receptors of human lymphocytes. Neuropharmacology 34, 427-431 (1995)